Prosecution Insights
Last updated: April 19, 2026

Friedrich Miescher Institute For Biomedical Research

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17996276 USE OF AN ORPHAN MOTIF TO INCREASE EXPRESSION OF A HETEROLOGOUS TRANSGENE HORTH, LISA ANNE 1681 Non-Final OA Oct 14, 2022
17756106 PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN AGMAT-POSITIVE CELLS IN LAYER 2/3 OF MOUSE CORTEX HILL, KEVIN KAI 1638 Final Rejection May 17, 2022

Managing Friedrich Miescher Institute For Biomedical Research's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month